Allelic imbalance at the HER2/TOP2A locus in breast cancer

about

Allelic imbalance at the HER2/TOP2A locus in breast cancer

Item

http://www.wikidata.org/entity/Q35663036

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Allelic imbalance at the HER2/TOP2A locus in breast cancer

@ast

Allelic imbalance at the HER2/TOP2A locus in breast cancer

@en

type

Item

label

Allelic imbalance at the HER2/TOP2A locus in breast cancer

@ast

Allelic imbalance at the HER2/TOP2A locus in breast cancer

@en

prefLabel

Allelic imbalance at the HER2/TOP2A locus in breast cancer

@ast

Allelic imbalance at the HER2/TOP2A locus in breast cancer

@en

P1476

Allelic imbalance at the HER2/TOP2A locus in breast cancer

@en

P2093

Adriaan J C van den Brule

http://www.w3.org/2001/XMLSchema#string

Cornelis J J Huijsmans

http://www.w3.org/2001/XMLSchema#string

Henny Rigter

http://www.w3.org/2001/XMLSchema#string

Jeroen Poodt

http://www.w3.org/2001/XMLSchema#string

Johannes C van der Linden

http://www.w3.org/2001/XMLSchema#string

Mirjam H A Hermans

http://www.w3.org/2001/XMLSchema#string

Mirrian Hilbink

http://www.w3.org/2001/XMLSchema#string

Paul H M Savelkoul

http://www.w3.org/2001/XMLSchema#string

P2860

Structure and function of type II DNA topoisomerases

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 International Study.

Breast tumor copy number aberration phenotypes and genomic instability

Amplification of HER2 is a marker for global genomic instability.

Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22

P2888

s13000-015-0289-x

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13000-015-0289-X

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1027942264

http://www.w3.org/2001/XMLSchema#string

P698

26022247

http://www.w3.org/2001/XMLSchema#string

P932

4448206

http://www.w3.org/2001/XMLSchema#string